GOTHENBURG, Sweden, March 22, 2012 /PRNewswire/ --
The new Dynaflow Resolve System was developed in close collaboration with leading ion-channel research groups to meet the demand for a simpler technology capable of complex perfusion protocols. The Dynaflow Resolve System is an advanced automated perfusion system that enables novel experimental protocols by allowing recording of any ion channel current, using any cell type, and any compound. The new and improved system retains all the advantages from the previously validated Dynaflow technology and now features the Resolve Glass Chip, providing reusability and adsorption-free perfusion.
"We are very impressed and happy with the data quality the Dynaflow Resolve Glass Chip is providing, both from cell lines and acutely isolated striatal neurons." says Ari-Pekka Koivisto, PhD, Orion Pharma, Finland.
The Dynaflow Resolve chip is made out of glass and has been developed based on customer requirements to minimize adsorption of highly hydrophobic compounds. Besides complete experimental freedom the chip offers reusability and improved cost-efficiency.
"The Dynaflow Resolve chip has solved our problems with difficult compounds and also offers complete flexibility well controlled perfusion and reusability with easy cleaning." Jessica Strömberg, PhD, Umecrine, Umeå, Sweden.
With the launch of the improved Dynaflow Resolve Glass Chip and System, Cellectricon will discontinue the production of the disposable plastic chips by the end of June 2012. Cellectricon offers new and existing customers the ability to take advantage of the benefits of this new technology.
Cellectricon, is a leading provider of advanced compound screening technologies and services to accelerate drug discovery and cell-based assay research. Our proprietary technologies include leading systems for high resolution ion-channel screening and cell engineering. Developed in close collaboration with leaders in the pharmaceutical industry and esteemed research labs, the Cellaxess® Technology enables scalable field stimulation, compound delivery and transfection for genomic screening of primary cells, neurones and stem cells. The Dynaflow® Technology advances ion channel research and discovery applications.